Lite Strategy, Inc. (LITS)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
1.20 USD
+0.03
(2.137%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 6:19 a.m. EDT
The investment case here is fractured between a desperate fundamental reality and a speculative price rebound. Fundamentally, the business is in freefall; the company has endured five consecutive years of negative annual returns, with the stock down nearly 93% over the last nine years. The balance sheet shows severe distress with negative free cash flow and negative equity returns, indicating the core operations are destroying value. While the company is executing a massive share buyback program to prop up the per-share value of its Litecoin holdings, this is a capital structure maneuver, not a sign of operational health. However, the short-term outlook is not hopeless due to a stark divergence in sentiment. Options data reveals a heavy concentration of call buying at strikes significantly above the current price, with almost zero put activity. This indicates that traders are positioning for a sharp bounce, likely driven by the buyback mechanics and the rebranding narrative. The statistical forecasting model offers no help, citing very low reliability, which forces us to rely on the visible options flow. The result is a neutral-to-slightly-bearish short-term rating because the fundamental rot is too deep to ignore, even if the immediate catalysts might spark a temporary rally. Long-term, this is a value trap where the market has correctly priced out the deteriorating business quality. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.084453 |
| AutoETS | 0.084454 |
| AutoTheta | 0.084844 |
| MSTL | 0.085027 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 24% |
| H-stat | 9.50 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 1.29 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2023-11-15 |
| Last Dividend Date | 2023-11-15 |
| Market Cap | 36,336,688 |
| Beta | 0.01 |
| Previous Name | MEI Pharma, Inc. |
| Website | https://www.litestrategy.com |
As of Oct. 10, 2026, 6:19 a.m. EDT: Speculators are overwhelmingly bullish on upside potential, evidenced by significant open interest in out-of-the-money calls (strikes at 2.5 and 5.0) across multiple expirations, while put activity is virtually non-existent. This asymmetry suggests a speculative bet on a price recovery rather than hedging against further declines.
| Date | Dividend | Yield % |
|---|---|---|
| 2023-11-16 | 1.75 | 28.501629 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.35135138 |
| Address1 | 9,920 Pacific Heights Blvd. |
| Address2 | Suite 150 |
| All Time High | 15,720.0 |
| All Time Low | 0.69 |
| Ask | 1.27 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 540,600 |
| Average Daily Volume3 Month | 470,912 |
| Average Volume | 470,912 |
| Average Volume10Days | 540,600 |
| Beta | 0.007 |
| Bid | 1.18 |
| Bid Size | 1 |
| Book Value | 1.284 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.195 |
| Current Ratio | 5.745 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.21 |
| Day Low | 1.13 |
| Display Name | Lite Strategy |
| Dividend Date | 1,701,820,800 |
| Dividend Yield | 0.0 |
| Earnings Timestamp | 1,790,685,000 |
| Earnings Timestamp End | 1,794,573,000 |
| Earnings Timestamp Start | 1,794,573,000 |
| Ebitda | -11,701,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.618 |
| Enterprise Value | 30,630,686 |
| Eps Trailing Twelve Months | -2.03 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,700,092,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.1156 |
| Fifty Day Average Change | 0.07940006 |
| Fifty Day Average Change Percent | 0.07117252 |
| Fifty Two Week Change Percent | -35.13514 |
| Fifty Two Week High | 2.26 |
| Fifty Two Week High Change | -1.0649999 |
| Fifty Two Week High Change Percent | -0.4712389 |
| Fifty Two Week Low | 0.69 |
| Fifty Two Week Low Change | 0.50500005 |
| Fifty Two Week Low Change Percent | 0.7318841 |
| Fifty Two Week Range | 0.69 - 2.26 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,071,757,800,000 |
| Float Shares | 28,202,437 |
| Free Cashflow | -6,701,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Fullday Change | 0.025000095 |
| Fullday Change Percent | 2.1367605 |
| Fullday Price | 1.195 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.013789999 |
| Held Percent Institutions | 0.19364999 |
| Implied Shares Outstanding | 30,407,268 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,700,092,800 |
| Last Dividend Value | 1.75 |
| Last Fiscal Year End | 1,782,777,600 |
| Last Split Date | 1,681,689,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California. |
| Long Name | Lite Strategy, Inc. |
| Market | us_market |
| Market Cap | 36,336,688 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_2214205 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-16 |
| Net Income To Common | -71,150,000 |
| Next Fiscal Year End | 1,814,313,600 |
| Non Diluted Market Cap | 40,149,736 |
| Open | 1.15 |
| Operating Cashflow | -9,121,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.22 |
| Phone | 858 369 7100 |
| Prev Name | MEI Pharma, Inc. |
| Previous Close | 1.17 |
| Price Hint | 4 |
| Price To Book | 0.93068534 |
| Profit Margins | 0.0 |
| Quick Ratio | 5.338 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0250001 |
| Regular Market Change Percent | 2.13676 |
| Regular Market Day High | 1.21 |
| Regular Market Day Low | 1.13 |
| Regular Market Day Range | 1.13 - 1.21 |
| Regular Market Open | 1.15 |
| Regular Market Previous Close | 1.17 |
| Regular Market Price | 1.195 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 317,674 |
| Return On Assets | -0.24741 |
| Return On Equity | -2.43024 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 30,407,268 |
| Shares Percent Shares Out | 0.0061000003 |
| Shares Short | 185,289 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 253,344 |
| Short Name | Lite Strategy, Inc. |
| Short Percent Of Float | 0.0062 |
| Short Ratio | 0.21 |
| Source Interval | 15 |
| State | CA |
| Symbol | LITS |
| Total Cash | 5,706,000 |
| Total Cash Per Share | 0.188 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.03 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.1091 |
| Two Hundred Day Average Change | 0.08590007 |
| Two Hundred Day Average Change Percent | 0.077450246 |
| Type Disp | Equity |
| Volume | 317,674 |
| Website | https://www.litestrategy.com |
| Zip | 92,121 |